Acute Biphenotypic Leukemia (ABL) Not Yet Recruiting Phase 2 Trials for Azacitidine (DB00928)

Also known as: Acute biphenotypic leukaemia / Acute Biphenotypic Leukemia / Leukemia, Biphenotypic, Acute / Acute bilineal leukemia

IndicationStatusPhase
DBCOND0081399 (Acute Biphenotypic Leukemia (ABL))Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04128501Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant SettingTreatment